- Home
- SNTG vs PTHL Comparison
SNTG vs PTHL Comparison
Compare SNTG & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTG
- PTHL
- Stock Information
- Founded
- SNTG 2009
- PTHL 1998
- Country
- SNTG China
- PTHL China
- Employees
- SNTG N/A
- PTHL N/A
- Industry
- SNTG Finance: Consumer Services
- PTHL
- Sector
- SNTG Finance
- PTHL
- Exchange
- SNTG Nasdaq
- PTHL Nasdaq
- Market Cap
- SNTG 8.2M
- PTHL 8.8M
- IPO Year
- SNTG 2021
- PTHL 2024
- Fundamental
- Price
- SNTG $2.07
- PTHL $0.62
- Analyst Decision
- SNTG
- PTHL
- Analyst Count
- SNTG 0
- PTHL 0
- Target Price
- SNTG N/A
- PTHL N/A
- AVG Volume (30 Days)
- SNTG 15.0K
- PTHL 119.5K
- Earning Date
- SNTG 12-16-2025
- PTHL 01-01-0001
- Dividend Yield
- SNTG N/A
- PTHL N/A
- EPS Growth
- SNTG N/A
- PTHL N/A
- EPS
- SNTG N/A
- PTHL N/A
- Revenue
- SNTG $107,507.00
- PTHL $448,196.00
- Revenue This Year
- SNTG N/A
- PTHL N/A
- Revenue Next Year
- SNTG N/A
- PTHL N/A
- P/E Ratio
- SNTG N/A
- PTHL N/A
- Revenue Growth
- SNTG N/A
- PTHL N/A
- 52 Week Low
- SNTG $1.43
- PTHL $0.47
- 52 Week High
- SNTG $12.70
- PTHL $32.00
- Technical
- Relative Strength Index (RSI)
- SNTG 35.11
- PTHL 35.82
- Support Level
- SNTG $1.90
- PTHL $0.58
- Resistance Level
- SNTG $2.33
- PTHL $0.63
- Average True Range (ATR)
- SNTG 0.15
- PTHL 0.06
- MACD
- SNTG -0.05
- PTHL 0.03
- Stochastic Oscillator
- SNTG 11.21
- PTHL 58.50
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.